Hepatitis B reactivation after chemotherapy: two decades of clinical research
β Scribed by George K. K. Lau
- Book ID
- 107593755
- Publisher
- Springer-Verlag
- Year
- 2008
- Tongue
- English
- Weight
- 316 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1936-0533
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis B virus (HBV) DNA is detectable in a number of liver transplant candidates who are negative for hepatitis B surface antigen (HBsAg). After liver transplantation (LT), such patients may have molecular and/or serologic evidence of HBV replication. However, clinical disease from reactivation
Hepatitis B virus (HBV) immune globulin (HBIg) administration will prevent HBV graft reinfection in HBV patients after orthotopic liver transplantation (OLT). However, the expenditure for such prophylaxis is extremely high ranging between $2,000 to $10,000 per month in various countries for an undef